DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

New look. Same commitment. Decision Resources Group becomes Clarivate. Read more here

The COVID-19 pandemic has thrust the medical device industry into an unprecedented situation, highlighting existing challenges and opportunities surrounding care provision efficiency. In particular, the pandemic has further solidified the procedural shift away from the hospital setting and toward ASCs, which played a significant role in market recovery as procedures that were deferred toward the beginning of the pandemic were gradually resumed.

In this E-Book, we outline the reasoning behind the pre-pandemic shift away from inpatient settings and highlight how the pandemic has in many ways accelerated this trend; in addition, we explore the present and potential future challenges associated with the growing significance of ASCs in the health care landscape, and draw from internal data and industry expert input to provide industry stakeholders with insights surrounding the future of site-of-service trends.

Key Takeaways:

  • Ongoing procedure shift to ASCs will accelerate
  • ASCs will represent an increasingly significant aspect of strategic planning
  • Future healthcare system M&As will feature ASCs more prominently
  • Price and cost will be increasingly critical components in the competitive landscape

.